Efficacy and safety of fast-acting insulin aspart versus insulin aspart in children and adolescents with type 1 diabetes from Japan.
Sign Up to like & getrecommendations! Published in 2021 at "Endocrine journal"
DOI: 10.1507/endocrj.ej20-0116
Abstract: The aim of this post-hoc subgroup analysis, which was based on data from the treat-to-target, 26-week, onset 7 trial, was to confirm the efficacy and safety of fast-acting insulin aspart (faster aspart) versus insulin aspart… read more here.
Keywords: insulin aspart; faster aspart; children adolescents; aspart versus ... See more keywords